Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study

7Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In a traditional pharmacokinetics (PK), bioavailability (BA)/bioequivalence (BE) study, the same number of time points and sampling times are used for each subject. Often, an indirect inference is then made on some PK parameters such as area under the plasma concentration curve (AUC), maximum plasma concentration (Cmax), time to maximum plasma concentration (Tmax) or half-life. However, since these PK parameters are summarized from repeated measurements, a lot of information can be lost. The indirect inferences on some PK parameters are not always accurate. Taking the repeated measurements of the concentration curve into consideration, a functional linear model has been developed to compare concentration curves directly instead of the PK parameters. Considering the nature of repeated measurements, a multiple testing procedure is proposed to assess the equality of two concentration curves. A real data set is used to demonstrate the proposed procedure. Copyright © 2004 John Wiley & Sons, Ltd.

Cite

CITATION STYLE

APA

Liao, J. J. Z. (2005). Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study. Statistics in Medicine, 24(6), 883–891. https://doi.org/10.1002/sim.1977

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free